JUVEDERM® SKINVIVE

What is Juvederm® Skinvive?

Juvederm® Skinvive is an injectable dermal filler from Allergan Aesthetics, an AbbVie company. The FDA lists the product as SKINVIVE by JUVÉDERM, with approval dated May 11, 2023, under PMA supplement P110033/S059.

It contains cross-linked hyaluronic acid, BDDE crosslinking agent, and 0.3% lidocaine to reduce discomfort on injection. Unlike traditional fillers, Skinvive is placed intradermally using a microdroplet technique to improve cheek skin smoothness rather than restore volume or contour.

Product Specifications

• Active ingredient: Hyaluronic acid (HA), modified/cross-linked
• Strength: 12 mg/mL HA with 0.3% w/w lidocaine
• Product type: Injectable gel implant; HA microdroplet injectable
• Format: Prefilled syringe for intradermal injection
• Manufacturer: Allergan Aesthetics, an AbbVie company
• Regulatory status: FDA-approved in 2023 for cheek skin smoothness in adults over 21
• CAS number: Hyaluronic acid CAS 9004-61-9; lidocaine CAS 137-58-6
• Molecular type: Cross-linked hyaluronic acid glycosaminoglycan gel
• Storage: 2–25°C; do not freeze; protect from direct sunlight
• Intended use: Licensed aesthetic medicine practitioners only

How Is Juvederm® Skinvive Formulated?

Skinvive uses the VYC-12L formulation: hyaluronic acid at 12 mg/mL, cross-linked with BDDE (1,4-butanediol diglycidyl ether). BDDE cross-linking creates covalent bonds between HA chains, increasing the gel’s resistance to enzymatic degradation and extending its persistence in the dermis compared with non-cross-linked HA solutions.

The formulation is designed for intradermal placement rather than subdermal or supraperiosteal injection. Its lower gel stiffness and cohesivity, which is compared with volumizing VYCROSS-platform fillers, make it specifically suited to the superficial dermal layer, where it improves tissue hydration and cheek skin smoothness without producing structural augmentation.

In CE-marked markets, the same base formulation is available without lidocaine as Juvederm® Volite, with broader indications approved for additional facial and body areas. Practitioners should verify local prescribing information and current regulatory status before use. (Regulatory information current as of May 2026.)

How Long Does Juvederm® Skinvive Last?

Juvederm® Skinvive is used in licensed aesthetic settings for adults seeking improvement in cheek skin smoothness, particularly where roughness, fine textural irregularity, or reduced dermal hydration are the primary concerns.

In the pivotal clinical trial (Alexiades M et al., Dermatol Surg. 2023), Skinvive demonstrated a statistically significant improvement in cheek skin smoothness in a randomized, multicenter, evaluator-blinded, controlled study.

• The treatment results sustained for at least 6 months. 57.9% of treated participants achieved at least a 1-point improvement on the Allergan Cheek Smoothness Scale at one month compared with 4.5% in the no-treatment control group.
• 6% maintained this response at six months.

Moreover, Skinvive by Juvederm® reviews should be based on published clinical evidence rather than anecdotal or social media sources. Patient-reported outcome data also showed marked improvements in satisfaction with skin hydration, radiance, and overall appearance at one month, sustained through six months.

However, safety and effectiveness have not been established for treatment areas outside the cheeks, and use should follow approved labeling. Other Juvederm® products have separate indications for volume, contouring, or wrinkle correction and should not be used interchangeably with Skinvive without reviewing their specific labeling.

How Is Juvederm® Skinvive Administered?

Juvederm® Skinvive is administered by intradermal microdroplet injection into the cheeks using an ultrafine needle by a trained aesthetic practitioner. Injection depth, volume, and distribution pattern are determined by the treating clinician based on patient assessment and labeling guidance. Sessions typically last 30–45 minutes, with repeat treatments at 6-month intervals to maintain skin smoothness.

Treatment should be postponed if active skin sores, rashes, cysts, infection, or inflammatory skin lesions are present at the intended injection site. Practitioners should advise patients to report vision changes, stroke-like symptoms, skin whitening, or unusual pain during or shortly after treatment, as these may indicate intravascular injection.

What Are the Side Effects and Drug Interactions?

Common injection site reactions from injectables like Skinvive are (generally mild to moderate; most resolve within 30 days):

• Redness, swelling, and bruising
• Tenderness, pain, and discomfort
• Firmness, lumps, or bumps
• Discoloration and itching

This treatment can also carry serious risks (rare but clinically significant):

• Vascular occlusion, which is the unintentional intravascular injection may cause vision abnormalities, blindness, stroke, tissue necrosis, or permanent scarring
• Delayed inflammatory reactions
• Hypersensitivity events in patients with severe allergies, lidocaine sensitivity, or prior HA filler reactions

It’s vital for practitioners to discuss the following drug interactions and contraindications prior to treatment:

• Aspirin, NSAIDs, or anticoagulants: Increased bruising and bleeding risk
• Immunosuppressive therapy: Increased infection risk
• Recent or planned laser treatments, chemical peels, or resurfacing procedures: Pose a risk of inflammatory reaction
• Active skin infection or inflammation at the injection site: Postpone treatment if any of these are present

Juvederm® Skinvive Availability and Access

Juvederm® Skinvive is a prescription medical device and must be sourced through licensed medical, aesthetic, or pharmaceutical channels. Access requirements vary by country, distributor, and professional eligibility. Practitioners should verify current regulatory status, local approved indications, and storage requirements before procurement. For guidance on product availability, contact Doctor Medica customer service.

Explore the complete catalog to buy JUVEDERM® online with wholesale options available for professional use.